Concepedia

Jessica Adickes

JA

Statistics

Publications

3

Citations

2.5K

H-Index

3

Active since

2008

Affiliations

Abbott Fund(Current)

Jessica Adickes is an author at Abbott Fund specializing in anti-apoptotic bcl-2 protein inhibition, pharmacology, and oncology pharmacology.

Publications per year

2008–2008

3

Publications

3

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor

Christin Tse, Alexander R. Shoemaker, Jessica Adickes et al. · Cancer Research · 2008 · 2K citations · Full text

, , +16

Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins

Cheol‐Min Park, Milan Bruncko, Jessica Adickes et al. · Journal of Medicinal Chemistry · 2008 · 293 citations · Full text

, , +16

Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models

Alex R. Shoemaker, Michael J. Mitten, Jessica Adickes et al. · Clinical Cancer Research · 2008 · 209 citations

, , +12

1–3 of 3